Skip to content 
The fund is an actively-managed exchange-traded fund (ETF) that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution (Genomics Revolution Companies). It is non-diversified. more
| Time Frame | ARKG | S&P500 |
|---|---|---|
| 1-Week Return | 5.01% | 1.04% |
| 1-Month Return | 8.38% | 5.46% |
| 3-Month Return | 7.19% | 9.3% |
| 6-Month Return | 2.79% | 9.79% |
| 1-Year Return | 51.94% | 27.71% |
| 3-Year Return | 1.07% | 78.75% |
| 5-Year Return | -60.78% | 78.69% |
| 10-Year Return | 78.81% | 258.35% |
| Stock name | Ticker | Weight |
|---|---|---|
 CRISPR THERAPEUTICS AG | CRSP | 8.32% |
 TEMPUS AI INC-CL A | TEM | 8.18% |
 TWIST BIOSCIENCE CORP | TWST | 8.04% |
 10X GENOMICS INC-CLASS A | TXG | 6.24% |
 PERSONALIS INC | PSNL | 5.23% |
 BEAM THERAPEUTICS INC | BEAM | 4.89% |
 ABSCI CORP | ABSI | 4.83% |
 GUARDANT HEALTH INC | GH | 4.68% |
 ILLUMINA INC | ILMN | 4.57% |
 NATERA INC | NTRA | 4.42% |
 VERACYTE INC | VCYT | 3.56% |
 INTELLIA THERAPEUTICS INC | NTLA | 3.47% |
 CAREDX INC | CDNA | 3.26% |
 RECURSION PHARMACEUTICALS-A | RXRX | 3.05% |
 COMPASS PATHWAYS PLC | CMPS | 2.96% |
 ADAPTIVE BIOTECHNOLOGIES | ADPT | 2.33% |
 NURIX THERAPEUTICS INC | NRIX | 2.32% |
 SCHRODINGER INC | SDGR | 2.12% |
 IONIS PHARMACEUTICALS INC | IONS | 1.77% |
 BUTTERFLY NETWORK INC | BFLY | 1.76% |
 GENEDX HOLDINGS CORP | WGS | 1.68% |
 CERUS CORP | CERS | 1.63% |
 ARCTURUS THERAPEUTICS HOLDIN | ARCT | 1.57% |
 ATAIBECKLEY INC | ATAI | 1.47% |
 PRIME MEDICINE INC | PRME | 1.14% |
 908 DEVICES INC | MASS | 1.12% |
 PACIFIC BIOSCIENCES OF CALIF | PACB | 1.06% |
 ELI LILLY & CO | LLY | 1.05% |
 ALAMAR BIOSCIENCES INC | ALMR | 0.99% |
 BIONTECH SE-ADR | BNTX | 0.94% |
 GENERATE BIOMEDICINES INC | GENB | 0.54% |
 QUANTUM-SI INC | QSI | 0.5% |
 GOLDMAN FS TRSY OBLIG INST 468 | GOLDMAN.FS.TRSY.OBLIG.INST.468 | 0.33% |
| Sector | Weight |
|---|---|
|
Health care | 100.00% |
ARK Genomic Revolution ETF (ARKG) share price today is $34.154.
Yes, Indians can buy shares of ARK Genomic Revolution ETF (ARKG) on Vested. To buy ARKG from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of ARK Genomic Revolution ETF (ARKG) on Vested. You can start investing in ARK Genomic Revolution ETF (ARKG) with a minimum investment of $1.
The 52-week high price of ARK Genomic Revolution ETF (ARKG) is $34.39. The 52-week low price of ARK Genomic Revolution ETF (ARKG) is $20.46.
The stock symbol (or ticker) of ARK Genomic Revolution ETF is ARKG.
Yes, you can setup SIP in ARK Genomic Revolution ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of ARKG on the Vested app.
The expense ratio of ARK Genomic Revolution ETF (ARKG) is 0.75%.
Link copied 
